Woodmont Investment Counsel’s iShares Biotechnology ETF IBB Stock Holding History

Woodmont Investment Counsel’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-321	Closed	-$31K	–	389
2016 Q3	$31K	Buy	+321	New	+$30.5K	0.01%	308
2016 Q2	–	Sell	-606	Closed	-$53K	–	313
2016 Q1	$53K	Hold	606	–	–	0.02%	251
2015 Q4	$68K	Buy	606 +285	+89%	+$30.9K	0.02%	238
2015 Q3	$32K	Hold	321	–	–	0.01%	305
2015 Q2	$39K	Buy	+321	New	+$38.4K	0.01%	282
2013 Q4	–	Sell	-8,205	Closed	-$573K	–	198
2013 Q3	$573K	Sell	8,205 -195	-2%	-$12.8K	0.21%	119
2013 Q2	$487K	Buy	+8,400	New	+$486K	0.16%	140

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Woodmont Investment Counsel's IBB Position: Q4 2016 in Review

Woodmont Investment Counsel sold out of iShares Biotechnology ETF (IBB) in Q4 2016, closing a stake of 321 shares — an estimated $31K sold.

Woodmont Investment Counsel first reported a position in IBB in Q2 2013 and held it in 7 quarters. The position peaked at $573K in Q3 2013. 523 funds tracked by Wall St. Rank hold IBB as of Q4 2016.

Woodmont Investment Counsel reported no remaining iShares Biotechnology ETF position as of Q4 2016 after selling out during the quarter.
Woodmont Investment Counsel sold 321 iShares Biotechnology ETF shares in Q4 2016, an estimated $31K.
Woodmont Investment Counsel first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 7 quarters.
Woodmont Investment Counsel's iShares Biotechnology ETF position peaked at $573K in Q3 2013.
523 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2016.

Based on Woodmont Investment Counsel's 13F filing for Q4 2016, filed 13 Feb 2017.